Risk Factors and Protective Factors Drug use is found among all ages, genders, races, socioeconomic statuses, educational levels, and cultures. Throughout the course, you will follow the stor
Risk Factors and Protective Factors
Drug use is found among all ages, genders, races, socioeconomic statuses, educational levels, and cultures. Throughout the course, you will follow the story of Aaliyah where you will apply the concepts you learn. In this module, you will meet Aaliyah and get to know her current situation.
Click to download transcript ( open in new tab and it will give you the case study).
Analyze the case study and review your readings. Respond to the following:
Identify and analyze Aaliyah’s risk and protective factors for drug use. Describe at least two factors for each.
Discuss at least one thing not mentioned in the case study that could be an additional risk factor or protective factor for Aaliyah.
Explain what these risk and protective factors imply for future substance use.
Get Answer Now
Order This Solution
49051 Millions developed by 10% and working benefit in 2009 was 15012 Millions that developed by 6%. Roche is contributed CHF. 9874 Millions on R&D in 2009. The free trade stream out 2009 was 8893 that was 79% more than 2008. The aggregate representative of Roche are 81507. Out of them 80115 are changeless. The Sales commitment is more from US that is 38% than West Europe that is 28%. Since pharmaceutical advertising exercises impact the endorsing conduct of specialists, it is of most extreme significance to basically dissect the cases made in the limited time material of the medications. The degree to which pharmaceutical organizations advance the benefits of their items and applicable clinical trails give to specialists are not examined in Pakistan. The consequences of the present logical examination demonstrate that untrustworthy and one-sided claims with respect to the pharmaceutical items are uncontrolled in Pakistan. These medication advancements impact the recommending conduct of the General Practitioners, Consultants in this manner representing one of the possibly significant reasons for outlandish solution. Roche Pakistan Ltd is a Member of IFPMA and PMA and take after their moral business rules to offer its items. Roche Paksitan Ltd is at sixth positioning in Pakistan Pharmaceutical Market and its yearly deal is Rs. 5.2 Billions out of 2009 in Pakistan.>GET ANSWER